Cargando…
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817103/ https://www.ncbi.nlm.nih.gov/pubmed/27015285 http://dx.doi.org/10.1038/bcj.2016.21 |
_version_ | 1782424840702001152 |
---|---|
author | Ratner, L Rauch, D Abel, H Caruso, B Noy, A Barta, S K Parekh, S Ramos, J C Ambinder, R Phillips, A Harding, J Baydoun, H H Cheng, X Jacobson, S |
author_facet | Ratner, L Rauch, D Abel, H Caruso, B Noy, A Barta, S K Parekh, S Ramos, J C Ambinder, R Phillips, A Harding, J Baydoun, H H Cheng, X Jacobson, S |
author_sort | Ratner, L |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4817103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48171032016-04-14 Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma Ratner, L Rauch, D Abel, H Caruso, B Noy, A Barta, S K Parekh, S Ramos, J C Ambinder, R Phillips, A Harding, J Baydoun, H H Cheng, X Jacobson, S Blood Cancer J Letter to the Editor Nature Publishing Group 2016-03 2016-03-25 /pmc/articles/PMC4817103/ /pubmed/27015285 http://dx.doi.org/10.1038/bcj.2016.21 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Letter to the Editor Ratner, L Rauch, D Abel, H Caruso, B Noy, A Barta, S K Parekh, S Ramos, J C Ambinder, R Phillips, A Harding, J Baydoun, H H Cheng, X Jacobson, S Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma |
title | Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma |
title_full | Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma |
title_fullStr | Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma |
title_full_unstemmed | Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma |
title_short | Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma |
title_sort | dose-adjusted epoch chemotherapy with bortezomib and raltegravir for human t-cell leukemia virus-associated adult t-cell leukemia lymphoma |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817103/ https://www.ncbi.nlm.nih.gov/pubmed/27015285 http://dx.doi.org/10.1038/bcj.2016.21 |
work_keys_str_mv | AT ratnerl doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT rauchd doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT abelh doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT carusob doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT noya doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT bartask doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT parekhs doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT ramosjc doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT ambinderr doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT phillipsa doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT hardingj doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT baydounhh doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT chengx doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma AT jacobsons doseadjustedepochchemotherapywithbortezomibandraltegravirforhumantcellleukemiavirusassociatedadulttcellleukemialymphoma |